Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniele Pievani"'
Autor:
Corinne Antoine, Christine Randoux, Océane Le Goff, Evangeline Pillebout, Imad Abboud, Daniele Pievani, Blandine Denis, Alexandra Delion, Denis Glotz, Carmen Lefaucheur, Michelle Elias, Clarisse Greze, Eric Daugas, Kevin Louis
Publikováno v:
J Am Soc Nephrol
BACKGROUND: COVID-19 has been associated with high morbidity and mortality in kidney transplant recipients. However, risk factors for COVID-19 disease in patients with kidney transplants remain poorly defined. METHODS: We enrolled patients who underw
Autor:
Jean-Paul Duong Van Huyen, Christophe Legendre, Alexandre Loupy, Olivier Aubert, Denis Glotz, Yassine Bouatou, Daniele Pievani, Marion Rabant, Denis Viglietti, Carmen Lefaucheur, Jean-Luc Taupin, Kevin Louis
Publikováno v:
American Journal of Transplantation. 19:1972-1988
The recent recognition of complex and chronic phenotypes of T cell-mediated rejection (TCMR) has fostered the need to better evaluate the response of acute TCMR-a condition previously considered to lack relevant consequences for allograft survival-to
Autor:
Carmen Lefaucheur, Denis Viglietti, Denis Glotz, Alexandre Loupy, Daniele Pievani, Kevin Louis, Christophe Legendre
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Alexandre Loupy, Denis Viglietti, Yassine Bouatou, Olivier Aubert, Denis Glotz, Christophe Legendre, Jean-Paul Duong Van Huyen, Carmen Lefaucheur, Daniele Pievani
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Jean-Luc Taupin, Denis Viglietti, Aurélie Philippe, Olivier Aubert, Denis Glotz, Jean-Paul Duong Van Huyen, Duska Dragun, Christophe Legendre, Philip F. Halloran, Daniele Pievani, Yassine Bouatou, Carmen Lefaucheur, Alexandre Loupy
Publikováno v:
Kidney International
Kidney International, Nature Publishing Group, 2019, 96, pp.189-201. ⟨10.1016/j.kint.2019.01.030⟩
Kidney International, Nature Publishing Group, 2019, 96, pp.189-201. ⟨10.1016/j.kint.2019.01.030⟩
Anti-angiotensin II type 1 receptor (AT1R) antibodies have been associated with allograft rejection. We hypothesized that circulating AT1R antibodies might identify kidney transplant recipients at increased risk of allograft rejection and loss who ar